Acadia Pharmaceuticals, Inc.

Acadia Pharmaceuticals reports quarterly loss of $9.5 million

Published in Pharma Investments, Ventures and Law Weekly, June 4th, 2006

Acadia Pharmaceuticals, Inc., (ACAD) a biopharmaceutical company using technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, reported its unaudited financial results for the first quarter ended March 31, 2006.

Acadia reported a net loss of $9.5 million for the first quarter of 2006 compared to a net loss of $5.6 million for the first quarter of 2005. The net loss for the first quarter of 2006 and 2005 included $900,000 and $371,000, respectively, in non-cash, stock-based compensation expense.

At March 31, 2006, Acadia's cash, cash equivalents, investment securities, and restricted cash...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-06-04)

More Articles from Pharma Investments, Ventures and Law Weekly

A.P. Pharma, Inc.
A.P. Pharma reports income of $0.75 per share; phase III trial for APF530 initiated
Abiomed, Inc.
Abiomed reports revenue is up 28% to $13.8 million
Aceto Corp.
Aceto announces earnings per share of $0.11
Adherex Technologies, Inc.
Adherex announces US$6.5 million private placement
Adolor Corp.
Adolor reports loss of $0.42 per share
Adventrx Pharmaceuticals, Inc.
Adventrx Pharmaceuticals posts loss of $0.31 per share
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry